We are live on ! Find out more
AIM

Arcadia Investment Management Portfolio holdings

AUM $584M
1-Year Est. Return 21.44%
This Fund
S&P 500
This Quarter Est. Return
+10.35%
1 Year Est. Return
+21.44%
3 Year Est. Return
+83.48%
5 Year Est. Return
+113.71%
10 Year Est. Return
+434.1%
AUM
$565M
AUM Growth
+$42.1M
Cap. Flow
-$2.06M
Cap. Flow %
-0.36%
Top 10 Hldgs %
37.22%
Holding
341
New
23
Increased
52
Reduced
104
Closed
29

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$1.56M
2
PEP icon
PepsiCo
PEP
+$1.42M
3
TT icon
Trane Technologies
TT
+$1.18M
4
AVGO icon
Broadcom
AVGO
+$1.17M
5
TSCO icon
Tractor Supply
TSCO
+$1.04M

Sector Composition

Rank Sector Weight
1 Technology 36.21%
2 Healthcare 13.53%
3 Consumer Discretionary 10.22%
4 Industrials 8.96%
5 Financials 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELV icon
201
Elevance Health
ELV
$84.7B
$51.9K 0.01%
100
AVAV icon
202
AeroVironment
AVAV
$9.74B
$49.8K 0.01%
325
-2
-0.6% -$267
AMGN icon
203
Amgen
AMGN
$224B
$49.8K 0.01%
175
-1,601
-90% -$468K
FRPT icon
204
Freshpet
FRPT
$3.5B
$49.5K 0.01%
427
+79
+23% +$7.64K
NTRA icon
205
Natera
NTRA
$45.9B
$49.2K 0.01%
538
+174
+48% +$13.1K
ATEC icon
206
Alphatec Holdings
ATEC
$1.47B
$48.8K 0.01%
3,544
-691
-16% -$10.2K
VTI icon
207
Vanguard Morningstar Total Stock Market ETF
VTI
$690B
$48.1K 0.01%
185
+169
+1,056% +$41.8K
DWX icon
208
State Street SPDR S&P International Dividend ETF
DWX
$529M
$45.7K 0.01%
1,300
MELI icon
209
Mercado Libre
MELI
$97.5B
$45.4K 0.01%
30
-10
-25% -$16.4K
BSX icon
210
Boston Scientific
BSX
$74.3B
$42.9K 0.01%
626
EXLS icon
211
EXL Service
EXLS
$5.32B
$42.7K 0.01%
1,344
+271
+25% +$8.43K
SLB icon
212
SLB Ltd
SLB
$79.3B
$40.8K 0.01%
745
MEDP icon
213
Medpace
MEDP
$16.9B
$40.8K 0.01%
101
+29
+40% +$10.2K
VGT icon
214
Vanguard Information Technology ETF
VGT
$147B
$36.7K 0.01%
560
SH icon
215
ProShares Short S&P500
SH
$845M
$35.6K 0.01%
750
-12,565
-94% -$629K
STIP icon
216
iShares 0-5 Year TIPS Bond ETF
STIP
$15.9B
$34.3K 0.01%
345
PGNY icon
217
Progyny
PGNY
$2.06B
$34.3K 0.01%
898
-2
-0.2% -$76
CYBR
218
DELISTED
CyberArk
CYBR
$34K 0.01%
+128
New +$31.7K
SIBN icon
219
SI-BONE Inc
SIBN
$859M
$34K 0.01%
2,075
-577
-22% -$10.9K
BWXT icon
220
BWX Technologies
BWXT
$15.5B
$32.3K 0.01%
315
IJR icon
221
iShares Core S&P Small-Cap ETF
IJR
$112B
$30.9K 0.01%
280
GUNR icon
222
FlexShares Global Upstream Natural Resources Index Fund
GUNR
$7.07B
$30.8K 0.01%
750
KRUS icon
223
Kura Sushi USA
KRUS
$593M
$30.3K 0.01%
264
-47
-15% -$4.56K
INSP icon
224
Inspire Medical Systems
INSP
$1.75B
$30.3K 0.01%
141
APPF icon
225
AppFolio
APPF
$7.13B
$30.1K 0.01%
122
-32
-21% -$6.9K

Similar funds

Arcadia Investment Management's Q1 2024 Portfolio in Review

As of Q1 2024, Arcadia Investment Management held 341 positions worth $565M, up 8% from $523M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Arcadia Investment Management's Q1 2024 filing shows 23 new, 52 increased, 104 reduced and 29 closed positions. Its largest new stake was Dyne Therapeutics: 31,325 shares worth $889K. The largest sale was Bristol-Myers Squibb, an estimated $1.56M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 37% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Arcadia Investment Management's largest Q1 2024 buy was Dyne Therapeutics: 31,325 shares worth $889K.
  • Arcadia Investment Management added most to Mobileye in Q1 2024, an estimated $2.8M increase.
  • Arcadia Investment Management's biggest Q1 2024 reduction was Bristol-Myers Squibb, cutting an estimated $1.56M.
  • Arcadia Investment Management fully exited East-West Bancorp in Q1 2024, selling an estimated $737K.
  • Arcadia Investment Management's ten largest holdings make up 37% of its $565M portfolio in Q1 2024.
  • Arcadia Investment Management opened 23 new positions and closed 29 in Q1 2024.
  • Arcadia Investment Management's portfolio value rose 8% quarter-over-quarter to $565M.

Based on Arcadia Investment Management's 13F filing for Q1 2024, filed 23 Apr 2024.